 | • レポートコード：GIR-22F19319 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Female Contraception Drug Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の女性用避妊薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 女性用避妊薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他 アプリケーション別セグメントは次のように区分されます。 ・診療所、病院、在宅医療 世界の女性用避妊薬市場の主要な市場プレーヤーは以下のとおりです。 ・Addex Therapeutics Ltd、Agile Therapeutics Inc、Bayer AG、Evofem Inc、Hervana Ltd、Mithra Pharmaceuticals SA、Orbis Biosciences Inc、Teva Pharmaceutical Industries Ltd、Viramal Ltd 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、女性用避妊薬製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な女性用避妊薬メーカーの企業概要、2019年～2022年までの女性用避妊薬の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な女性用避妊薬メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別女性用避妊薬の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの女性用避妊薬のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での女性用避妊薬市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および女性用避妊薬の産業チェーンを掲載しています。 ・第13、14、15章では、女性用避妊薬の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 女性用避妊薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：診療所、病院、在宅医療 - 世界の女性用避妊薬市場規模・予測 - 世界の女性用避妊薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Addex Therapeutics Ltd、Agile Therapeutics Inc、Bayer AG、Evofem Inc、Hervana Ltd、Mithra Pharmaceuticals SA、Orbis Biosciences Inc、Teva Pharmaceutical Industries Ltd、Viramal Ltd ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：AG-890、アンフォラ、BAY-1007626、ドロスピレノン、その他 ・アプリケーション別分析2017年-2028年：診療所、病院、在宅医療 ・女性用避妊薬の北米市場分析 - 女性用避妊薬の北米市場：タイプ別市場規模2017年-2028年 - 女性用避妊薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・女性用避妊薬のヨーロッパ市場分析 - ：女性用避妊薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：女性用避妊薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・女性用避妊薬のアジア太平洋市場分析 - 女性用避妊薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 女性用避妊薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・女性用避妊薬の南米市場分析 - 女性用避妊薬の南米市場：タイプ別市場規模2017年-2028年 - 女性用避妊薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・女性用避妊薬の中東・アフリカ市場分析 - 女性用避妊薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 女性用避妊薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Female Contraception Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Female Contraception Drug market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Clinic accounting for % of the Female Contraception Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While AG-890 segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Female Contraception Drug include Addex Therapeutics Ltd, Agile Therapeutics Inc, Bayer AG, Evofem Inc, and Hervana Ltd, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Female Contraception Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
AG-890
Amphora
BAY-1007626
Drospirenone
Others
Market segment by Application can be divided into
Clinic
Hospital
Homecare
The key market players for global Female Contraception Drug market are listed below:
Addex Therapeutics Ltd
Agile Therapeutics Inc
Bayer AG
Evofem Inc
Hervana Ltd
Mithra Pharmaceuticals SA
Orbis Biosciences Inc
Teva Pharmaceutical Industries Ltd
Viramal Ltd
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Female Contraception Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Female Contraception Drug, with price, sales, revenue and global market share of Female Contraception Drug from 2019 to 2022.
Chapter 3, the Female Contraception Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Female Contraception Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Female Contraception Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Female Contraception Drug.
Chapter 13, 14, and 15, to describe Female Contraception Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Female Contraception Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Female Contraception Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 AG-890
1.2.3 Amphora
1.2.4 BAY-1007626
1.2.5 Drospirenone
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Female Contraception Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Homecare
1.4 Global Female Contraception Drug Market Size & Forecast
1.4.1 Global Female Contraception Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Female Contraception Drug Sales in Volume (2017-2028)
1.4.3 Global Female Contraception Drug Price (2017-2028)
1.5 Global Female Contraception Drug Production Capacity Analysis
1.5.1 Global Female Contraception Drug Total Production Capacity (2017-2028)
1.5.2 Global Female Contraception Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Female Contraception Drug Market Drivers
1.6.2 Female Contraception Drug Market Restraints
1.6.3 Female Contraception Drug Trends Analysis
2 Manufacturers Profiles
2.1 Addex Therapeutics Ltd
2.1.1 Addex Therapeutics Ltd Details
2.1.2 Addex Therapeutics Ltd Major Business
2.1.3 Addex Therapeutics Ltd Female Contraception Drug Product and Services
2.1.4 Addex Therapeutics Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Agile Therapeutics Inc
2.2.1 Agile Therapeutics Inc Details
2.2.2 Agile Therapeutics Inc Major Business
2.2.3 Agile Therapeutics Inc Female Contraception Drug Product and Services
2.2.4 Agile Therapeutics Inc Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bayer AG
2.3.1 Bayer AG Details
2.3.2 Bayer AG Major Business
2.3.3 Bayer AG Female Contraception Drug Product and Services
2.3.4 Bayer AG Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Evofem Inc
2.4.1 Evofem Inc Details
2.4.2 Evofem Inc Major Business
2.4.3 Evofem Inc Female Contraception Drug Product and Services
2.4.4 Evofem Inc Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Hervana Ltd
2.5.1 Hervana Ltd Details
2.5.2 Hervana Ltd Major Business
2.5.3 Hervana Ltd Female Contraception Drug Product and Services
2.5.4 Hervana Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Mithra Pharmaceuticals SA
2.6.1 Mithra Pharmaceuticals SA Details
2.6.2 Mithra Pharmaceuticals SA Major Business
2.6.3 Mithra Pharmaceuticals SA Female Contraception Drug Product and Services
2.6.4 Mithra Pharmaceuticals SA Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Orbis Biosciences Inc
2.7.1 Orbis Biosciences Inc Details
2.7.2 Orbis Biosciences Inc Major Business
2.7.3 Orbis Biosciences Inc Female Contraception Drug Product and Services
2.7.4 Orbis Biosciences Inc Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Teva Pharmaceutical Industries Ltd
2.8.1 Teva Pharmaceutical Industries Ltd Details
2.8.2 Teva Pharmaceutical Industries Ltd Major Business
2.8.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Product and Services
2.8.4 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Viramal Ltd
2.9.1 Viramal Ltd Details
2.9.2 Viramal Ltd Major Business
2.9.3 Viramal Ltd Female Contraception Drug Product and Services
2.9.4 Viramal Ltd Female Contraception Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Female Contraception Drug Breakdown Data by Manufacturer
3.1 Global Female Contraception Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Female Contraception Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Female Contraception Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Female Contraception Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Female Contraception Drug Manufacturer Market Share in 2021
3.5 Global Female Contraception Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Female Contraception Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Female Contraception Drug Market Size by Region
4.1.1 Global Female Contraception Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Female Contraception Drug Revenue by Region (2017-2028)
4.2 North America Female Contraception Drug Revenue (2017-2028)
4.3 Europe Female Contraception Drug Revenue (2017-2028)
4.4 Asia-Pacific Female Contraception Drug Revenue (2017-2028)
4.5 South America Female Contraception Drug Revenue (2017-2028)
4.6 Middle East and Africa Female Contraception Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Female Contraception Drug Sales in Volume by Type (2017-2028)
5.2 Global Female Contraception Drug Revenue by Type (2017-2028)
5.3 Global Female Contraception Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Female Contraception Drug Sales in Volume by Application (2017-2028)
6.2 Global Female Contraception Drug Revenue by Application (2017-2028)
6.3 Global Female Contraception Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Female Contraception Drug Sales by Type (2017-2028)
7.2 North America Female Contraception Drug Sales by Application (2017-2028)
7.3 North America Female Contraception Drug Market Size by Country
7.3.1 North America Female Contraception Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Female Contraception Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Female Contraception Drug Sales by Type (2017-2028)
8.2 Europe Female Contraception Drug Sales by Application (2017-2028)
8.3 Europe Female Contraception Drug Market Size by Country
8.3.1 Europe Female Contraception Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Female Contraception Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Female Contraception Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Female Contraception Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Female Contraception Drug Market Size by Region
9.3.1 Asia-Pacific Female Contraception Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Female Contraception Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Female Contraception Drug Sales by Type (2017-2028)
10.2 South America Female Contraception Drug Sales by Application (2017-2028)
10.3 South America Female Contraception Drug Market Size by Country
10.3.1 South America Female Contraception Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Female Contraception Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Female Contraception Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Female Contraception Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Female Contraception Drug Market Size by Country
11.3.1 Middle East & Africa Female Contraception Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Female Contraception Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Female Contraception Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Female Contraception Drug
12.3 Female Contraception Drug Production Process
12.4 Female Contraception Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Female Contraception Drug Typical Distributors
13.3 Female Contraception Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer